Information on Cancer
users and public
ICO group
epidemiology and prevention area
research
training
ICO l'hospitalet
ICO badalona
ICO girona
 
fundacio institut catala d'oncologia
 
pla director d'oncologia

Biopol l’H, the biggest scientific and technology area in Catalonia, is born


Last October 10th. a covenant was signed for the development of the BioPol L’H project, the biggest scientific and technology area in Catalonia, located in Hospitalet de Llobregat. The signature was attended by Ms. Marina Geli ‘consellera’ of Health, the ‘conseller’ of Universities and Research, Mr. Joan Manuel del Pozo, the ‘conseller’ of Work and Industry, Mr. Jordi Valls, the rector of UB, Mr. Màrius Rubiralta, the mayor of l’Hospitalet, Mr. Celestino Corbacho and the chairman of the Bioregion, Mr. Joan Cornet.
Catalonia defines the biomedical sector as one of the greatest strategic axis for the development of our country. Thus, an impulse to the creation of scientific areas is a fundamental tool. The project Biopol L’H is presented in this context.
BioPol L’H has the objective of creating a scientific area in Hospitalet, in order to promote research, assistance and teaching on health science, at a new 300.000 sq. metres complex, which will be built on both sides of the Gran Via de l’Hospitalet. Biopol L’H will be formed by ICO l’Hospitalet –Duran i Reynals Hospital, Bellvitge Hospital, the University Campus de la Salut (UB), the Biomedical Research Institute of Bellvitge (IDIBELL), the Bioengineering Institute of Catalonia (IBEC), the Scientific Campus de la Salut and the Business Complex in Hospitalet.
BioPol L’H will be the background for creating new technology-based companies and mixed units of collaboration between the public and private sectors, while facilitating the search for excellence. All this will allow the interaction between university research, the productive sector and the technology background.
The areas which Biopol L’H will take part in are:
- cancer and human molecular genetics
- neuro-science
- infectious pathologies and transplants,
- growth factors, hormones and diabetes
- chronic and degenerative illnesses.